Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery synthesizes WEE1hu inhibitors

Aug. 9, 2018

Researchers present new NR1I2 agonists

Aug. 9, 2018

Bayer patents MKNK1 inhibitors

Aug. 9, 2018

Phase III study of Estelle oral contraceptive meets primary efficacy endpoint

Aug. 9, 2018

Immunose FLU nasal influenza vaccine candidate demonstrates good safety in older adults

Aug. 9, 2018

First participant enrolled in phase III study of M-001 universal flu vaccine candidate

Aug. 9, 2018

The exerkine apelin reverses age-associated sarcopenia

Aug. 9, 2018

Activin signaling underscores resistance to platinum-based chemotherapy in lung adenocarcinoma

Aug. 9, 2018

Plugging leaks in engineered vasculature

Aug. 9, 2018

New biological target for Alzheimer's identified in BioArctic/Eisai collaboration

Aug. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...